[1]连立芬,王岩岩,高亚梅,等.益母逐瘀汤联合人工周期治疗宫腔粘连分离术后患者肾虚血瘀证疗效及机制研究[J].陕西中医,2022,(7):857-860.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.009]
　LIAN Lifen,WANG Yanyan,GAO Yamei,et al.Effect and mechanism analysis of Yimu Zhuyu decoction combined with artificial cycle on kidney deficiency and blood stasis syndrome after intrauterine adhesion separation[J].,2022,(7):857-860.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.009]
点击复制

益母逐瘀汤联合人工周期治疗宫腔粘连分离术后患者肾虚血瘀证疗效及机制研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年7期
页码:
857-860
栏目:
临床研究
出版日期:
2022-07-05

文章信息/Info

Title:
Effect and mechanism analysis of Yimu Zhuyu decoction combined with artificial cycle on kidney deficiency and blood stasis syndrome after intrauterine adhesion separation
作者:
连立芬; 王岩岩; 高亚梅; 李鹏利
(秦皇岛市妇幼保健院,河北 秦皇岛 066000)
Author(s):
LIAN Lifen; WANG Yanyan; GAO Yamei; LI Pengli
(Maternity and Child Care Centre of Qinhuangdao,Qinhuangdao 066000,China)
关键词:
宫腔粘连分离术;  肾虚血瘀证;  益母逐瘀汤;  戊酸雌二醇;  地屈孕酮
Keywords:
Uterine cavity adhesion separation;  Kidney deficiency and blood stasis syndrome;  Yimu Zhuyu decoction;  Estradiol valerate;  Diprogesterone acetate
分类号:
R 271.9
DOI:
DOI:10.3969/j.issn.1000-7369.2022.07.009
文献标志码:
A
摘要:
目的:分析益母逐瘀汤联合人工周期治疗宫腔粘连分离术后患者肾虚血瘀证的疗效及机制。方法:选取90例宫腔粘连分离术后肾虚血瘀证患者随机分为人工周期组(45例)和中西结合组(45例)。人工周期组采用人工周期治疗,中西结合组在人工周期组的基础上加用益母逐瘀汤治疗,两组均治疗3个月经周期。统计两组治疗3个月经周期后的临床疗效,比较两组治疗前和治疗3个月经周期后血清血小板源性生长因子(PDGF)、纤细酶原激活物抑制物-1(PAI-1)、基质金属蛋白酶-9(MMP-9)水平、阴道彩色多普勒超声检查结果、宫腔粘连评分、肾虚血瘀证评分、月经恢复情况。结果:治疗3个月经周期后,中西结合组总有效率高于人工周期组(P<0.05)。治疗3个月经周期后与治疗前比较,两组血清PDGF、PAI-1水平及子宫动脉血流阻力指数(RI)、子宫动脉搏动指数(PI)、宫腔粘连、肾虚血瘀证评分降低,中西结合组低于人工周期组(P<0.05); 两组血清MMP-9水平、子宫内膜厚度、宫腔容积升高,中西结合组高于人工周期组(P<0.05)。治疗3个月经周期后与治疗前比较,两组经量正常、周期正常、经期正常患者占比升高,中西结合组高于人工周期组(P<0.05)。结论:益母逐瘀汤联合人工周期治疗宫腔粘连分离术后肾虚血瘀证患者,可有效抑制子宫内膜纤维化,改善患者子宫情况,促进患者月经恢复正常,具有较好的临床疗效。
Abstract:
Objective:To analyze the curative effect and mechanism of Yimu Zhuyu decoction combined with artificial cycle in treating kidney deficiency and blood stasis syndrome after intrauterine adhesion separation.Methods:A total of 90 patients with kidney deficiency and blood stasis syndrome after intrauterine adhesion separation were divided into the labor cycle group(45 cases)and the Chinese-western combination group(45 cases)by random number table method.The labor cycle group was treated with artificial cycle,while the Chinese-western combination group was treated with Yimu Zhuyu decoction on the basis of the labor cycle group.Both groups were treated for 3 menstrual cycles.The clinical effects of the two groups after 3 menstrual cycles were counted,and the levels of serum platelet-derived growth factor(PDGF),PAI-1 and MMP-9,color doppler ultrasonography,scores of intrauterine adhesion,kidney deficiency and blood stasis syndrome,and menstrual recovery were compared between the two groups before treatment and 3 menstrual cycles after treatment.Results:After 3 menstrual cycles,the total effective rate of the Chinese-western combination group was higher than that of the labor cycle group(P<0.05).After 3 menstrual cycles,the levels of serum PDGF and PAI-1 and uterine artery resistance index(RI),uterine artery pulsation index(PI),the scores of intrauterine adhesion and kidney deficiency and blood stasis in the two groups decreased compared with before treatment,and the Chinese-western combination group was lower than the labor cycle group(P<0.05); The level of serum MMP-9,endometrial thickness and uterine cavity volume of the two groups increased,and the Chinese-western combination group was higher than the labor cycle group(P<0.05).After 3 menstrual cycles,the proportion of patients with normal menstrual flow,normal menstrual cycle and normal menstrual period in the two groups increased compared with before treatment,and the Chinese-western combination group was higher than the labor cycle group(P<0.05).Conclusion:Yimu Zhuyu decoction combined with artificial cycle in the treatment of patients with kidney deficiency and blood stasis syndrome after intrauterine adhesion separation can effectively inhibit endometrial fibrosis,improve the patient's uterus,and promote the patient's menstruation to return to normal,and has a good clinical curative effect.

参考文献/References:

[1] Leung RK,Lin Y,Liu Y.Recent advances in understandings towards pathogenesis and treatment for intrauterine adhesion and disruptive insights from single-cell analysis[J].Reprod Sci,2021,28(7):1812-1826.
[2] 安沛兴,单 莉,楚光华,等.地屈孕酮联合戊酸雌二醇片对人工流产术后患者月经复潮时间及宫腔粘连发生率的影响[J].贵州医药,2021,45(2):241-242.
[3] 张洪涛,翁冬莉.防粘连膜联合助膜养宫汤对肾虚血瘀型重度宫腔粘连术后患者宫腔再粘连、凝血功能及血清TGF-β和TIMP-1的影响[J].现代中西医结合杂志,2018,27(14):1509-1512.
[4] 马本玲,张晓红,李 琳,等.补肾活血汤治疗中重度宫腔粘连TCRA术后患者及对纤维化因子的影响[J].中国实验方剂学杂志,2021,27(6):62-68.
[5] 李莉莉,周 艳.益母逐瘀汤联合西药治疗宫腔粘连分解术后中重度宫腔粘连临床研究[J].中国中医药信息杂志,2018,25(5):27-31.
[6] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2014:95-98.
[7] 张玉珍.新编中医妇科学[M].北京:人民军医出版社,2001:108-113.
[8] 王 丽,张莉莉,张丹妮.透明质酸钠凝胶联用人工周期对中重度宫腔粘连术后的疗效观察[J].长春中医药大学学报,2021,37(6):1397-1399.
[9] 徐新亚,张科群.补肾逐瘀汤对宫腔粘连分离术后肾虚血瘀证患者的疗效及对TGF-β1、PAI-1、MMP-9水平的影响[J].中药材,2019,42(1):222-225.
[10] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:78-80.
[11] Zhang X,Liu W,Zhou Y,et al.Comparison of therapeutic efficacy of three methods to prevent re-adhesion after hysteroscopic intrauterine adhesion separation:A parallel,randomized and single-center trial[J].Ann Palliat Med,2021,10(6):6804-6823.
[12] 张 璐,任 健.宫腔粘连患者宫腔镜下宫腔粘连分离术术后复发的危险因素分析[J].中国性科学,2021,30(8):92-95.
[13] 毛利云,朱 铮,王屹雯,等.补肾填精行气活血法治疗中重度宫腔粘连疗效研究[J].陕西中医,2020,41(12):1731-1734.
[14] 赵现立,南 燕,齐 进,等.中重度宫腔粘连宫腔镜电切术后两种方案预防再粘连临床研究[J].陕西医学杂志,2018,47(2):165-167.
[15] 曹亚芳,亓筱筱,吴 霜.白莲散结汤联合芬吗通对重度宫腔粘连术后子宫内膜的影响[J].中国计划生育和妇产科,2020,12(5):89-92.
[16] 曾 根,李兆萍,朱 晶.复膜汤保留灌肠对气虚血瘀型宫腔粘连术后再粘连的影响[J].中医学报,2020,35(6):1325-1329.
[17] 杨汉铭,赵宏利,陈思忆.厚胞汤加减预防宫腔粘连松解术后再粘连的临床研究[J].浙江中医药大学学报,2020,44(7):633-638.
[18] 汤锶锶,翁双燕.补肾活血法分期治疗联合宫腔灌注对重度宫腔粘连术后子宫内膜容受性及妊娠结局的影响[J].广州中医药大学学报,2020,37(3):426-431.
[19] 梁红霞,许建多,毛丽梅,等.滋肾化瘀汤在宫腔粘连纤维化进程中的疗效及对FoxF2、TGF-β1表达的影响[J].河北医药,2020,42(3):349-352.
[20] 伍 靓,张汉英,张立波,等.加味生化汤联合优思悦治疗对稽留流产清宫术患者月经恢复、宫腔粘连及妊娠率的影响[J].四川中医,2021,39(4):164-167.
[21] 方 昉,廖慧慧.补肾活血法联合T管预防宫腔粘连术后复发的临床效果[J].广州中医药大学学报,2020,37(12):2331-2336.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81802372); 河北省秦皇岛市卫生健康委员会科研课题(201805A062)
更新日期/Last Update: 2022-07-07